Current data has a 15-minute delay. Please / to get real-time quotes.
icon

AnaptysBio

ANAB

ANAB AnaptysBio NASDAQ
Add to watchlist
14.60
1.24 (+9.28 %)
At close : Jan 03, 16:00 ET
14.79
0.19 (+1.30 %)
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    ANAB Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 996.27k
    • Turnover 14.39M
    • P/E(TTM) --
    • Turnover % 3.83%
    • P/E(Static) --
    • Market Cap 444.26M
    • P/B 5.27
    • Shares 30.43M
    • 52 Week Range
      12.51
      41.31
    • Day Range
      13.74
      14.87

    About

    AnaptysBio, Inc., established in Delaware in November 2005. The company is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. The company is developing immune cell modulating antibodies, including two wholly owned...
    • Highlight
      A clinical-stage biotechnology company focused on innovative immunology therapeutics
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      01/26/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      117
    • Address
      10770 Wateridge Circle Suite 210 San Diego CA 92121
    • Tel
      1-858-3626295
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD